In the latest episode of the Alloutcoach Podcast I spoke with Dr.

The latest episode on the Alloutcoach podcast features a critical discussion with a globally recognized leader in improving healthcare and strengthening systems to deliver better outcomes, efficiency, and sustainability, Dr. Rashad Massoud, about improving global healthcare quality by focusing on the personal elements of delivery of equity of care. Dr. Massoud, MD, MPH, FACP is visiting faculty at Harvard T.H. Chan School of Public Health. He is an inaugural Member of the Quality & Safety Academy of the International Society for Quality (ISQua), Advisory Board Member of the World Health Organization (WHO)’s Global Report on Quality and Safety. Dr. Massoud has previously served as Senior Vice President and Chief Program Officer

2:52 What drove you to dedicate your career to improving healthcare quality on a global scale?

5:36 What is your expert definition of quality of healthcare?

8:51 What is your personal theory of quality improvement in healthcare?

11:57 What are the lessons you have learned from your experiences and case studuies in some of the health systems in which you have worked?

15:00 Can you take a step back and take us through the process of quality improvement and share specific highlights from a health system with which you worked?

21:06 Healthcare spending has tripled in the last 20 years while the life expectancy is at its lowest in the US over the same period. When is healthcare a cost versus an investment, and what do the latest healthcare spending trends really mean to us in terms of innovation?

27:28 How can pharma and biotech play a more proactive role in transforming healthcare from a cost into an investment based on your lessons?

31:20 What is the next project or milestone in which you are stretching yourself and lifting others?

In this podcast episode Stefano Puntoni, PhD, Wharton Professor in Marketing, Behavioral Scientist, and a renowned, award-winning expert in Data Analytics, Economics, Brand Management, and Consumer Research, reveals his lessons and views on making stronger decisions as humans alone as well as together with AI and technology or data with purpose in an unpredictable world. He deconstructs the decision making process and explains why outcomes alone are irrelevant, providing real world examples from the perspectives of an individual business executive, organization, and a consumer. Most of his ongoing research investigates how new technology is changing consumption and society - a very timely subject today, and he speaks about the role of decision driven science in radically innovative companies as well as an exciting new research initiative at The Wharton School which will stimulate more insights on the relationship between new technology and consumer behaviors.

2:43 Early passion for architecture and enjoyment of applying both

5:22 How the most innovative companies identify the unspoken needs

5:58 Difference between being market driven or market driving in radical

9:03 Creating the bridge between the person who best understands the

12:51 Unilever or Google are companies that are very advanced in

13:42 Ian Brown, Stanford Professor - "You can't judge decisions on

14:15 How to make the best decisions most quickly and at the right time

17:01 How can we train our intuition to make better decisions? Einstein:

21:20 Gird Gigerenzer: Intuition is instinctively knowing what to

22:06 How do you utilize AI or technology to make the right decisions on

22:36 Why very few real advertisers who know how to really do it well

26:44 Pharma case study of interpreting analytics from Medical Education

27:21 Problem-based learning in pharma is very effective - "WhatsApp"

28:22 Story of an Ad Campaign with the right SEO algorithm for Health

29:49 Tips for consumers can to make better decisions

31:36 How objective quality of marketed products relates to consumer

32:43 Stefano Puntoni is Co-Director with Bob Mayer of a new "Impact of

There has never been a more appropriate time than today to reinvigorate and add life to our workplace. To discuss why inspiring a certain company culture as well as innovation can increase engagement and performance, I interviewed Rebecca Friese, co-founder of FLYN, leading management consultant, keynote speaker and author of "The Good Culture: The Leader's Guide to Creating a Workplace that Doesn't Suck". By identifying outdated practices from the ground floor to the boardroom, Rebecca helps a wide range of organizations from Fortune 500 behemoths to hopeful start-ups, build the capacity to implement market-leading cultural changes. At the moment, Rebecca is on a mission to help organizations not just be better, but exceptionally innovative, engaging, and forward-thinking places to work. In our informal and candid conversation, we discuss how company culture becomes visible or invisible in a typical organization, why it influences performance, how we can keep ourselves accountable with KPIs or performance metrics for performance as well as behaviors or culture, growing culture over time despite successes and failures, why engagement and innovation is so relevant to all of us today, and real world case studies of leadership approaches to implement the environment or culture with intentionality that delivers innovation.

2:51 - Highlights from Rebecca's career

6:08 - Definition of Company Culture

8:22 - Rebecca's Signature Approach to assisting organizations with Company Culture

13:30 - Designing performance metrics/KPIs that inspire accountability for behavior and stimulate the best culture

13:48 - Without aligning culture to our everyday strategy and operationalizing it through metrics or accountability there is a gap which questions the value of the culture we want to design as leaders.

16:59 - Recent case study from a Tech company with a leader of a high-performing team that was asked to leave the organization

19:42 - New trending internal metrics of managers: manager engagement indicator (MEIs) surveys

22:04 - Metrics can improve a sense of belonging of an employee when you know what part of your effort contributes to the overall success of your organization

22:35 - Rebecca's personal real world story of being mislead to be performing well without any direct feedback

25:52 - Maintaining a certain culture through company successes and setbacks

30:59 - How Rebecca's approach to helping organizations with culture has changed over the last few years

31:21 - Focus on design thinking at FLYN Consulting

32:07 - Biggest challenge is to address the unspoken needs of individuals in the workplace

33:58 - How Rebecca is linking company culture to innovation with Fortune 500 companies

34:58 - People are motivated by their ability to learn and grow

35:08 - Customers often do not know or cannot yet imagine what they really need

36:52 - Explaining what "behavior" means to a 2-year old by adding incentives, transparency, feedback, consistency, and recognition

38:26 - Innovative organizations have to unlock the basic needs of all humans for autonomy, mastery, and purpose based on Daniel Pink's book "Drive"

40:18 - How everyone can be innovative in an organization

43:11 - How Rebecca is stretching herself and lifting others currently: her mission is to help people love their workplace

In this special episode I interviewed the winners of the first ever month-long Medical Affairs Innovation Olympics competition in pharma and biotech in the fall of 2022, CEO and Co-Founder of Discreedly, Vinay Tharayil, MD, BCMAS and Co-Founder and Chief Commercial Officer, Gibu George, MD. My guests discussed why education and interactions between pharmaceutical companies and healthcare providers need to evolve and how they are extending the reach and awareness of quality, fair-balanced medical education to not only academic physicians but those in the community using their platform, Discreedly.

1:55 - Vinay Tharayil - Background. GSK Vaccines. Medical Affairs Excellence and Operations at Astellas. Passion for Medical Affairs and the MSL role. MSLs bring lots of value to the healthcare system but often go under the radar.

4:59 - How they came up with the app @Discreedly

5:27 - Vinay and Gibu's vision and philosophy of Medical Affairs

5:46 - What makes Medical Affairs critical today in influencing health care?

6:43 - Main driver for Medical Affairs is education, scientific exchange and communication

8:53 - We want to bring medical education to the community of physicians, not just academic hospitals. Discreedly aims to increase the reach of Medical Affairs to a wider audience, including the community level physicians whom we typically do not target or educate.

11:57 - What is the relevance of a pharma company communicating more information to ensure access to care and health equity today?

13:33 - We can follow patients in EPIC via electronic health records, to be able to provide pricing information immediately.

14:14 - Putting the Provider in the Captain's Chair to be able to govern the direction of the frequency of the communications they prefer with Pharma, to allow access to quality medical information in a centralized platform.

15:12 - Physicians can search product information including formulary coverage, tier level on the health plan all at their fingertips.

15:30 - We are also exploring making social determinants of health related data available to them as well.

16:06 - Why did you call the platform "Discreedly"?

18:15 - How would pharma companies use the Discreedly App?

18:24 - Back-end channel for Pharma in this platform. Med Affairs companies will be uploading content, products, disease state related information, formulary, media that may be generated. MSLs may also be available on demand, virtually, ready to engage and educated HCPs. Providers can schedule meetings with Field MA or Medical Information. The program enables real time live chatting with HCPs, live updates / notifications.

21:39 - How do the users ensure alignment with their compliance and regulatory policies to guide what information may be shared on this platform?

22:19 - What part of the Discreedly program makes it more appropriate for the community level physicians?

23:29 - We secured a partnership with Doximity and use their SSO. They do not have to create a new account if they are already registered with Doximity.

25:30 - Extensive research of preferred formats of medical education shows high variability - the way many community oncologists learn about new treatments is a private WhatsApp group

27:02 - How does your program improve quality of healthcare at the clinical point of care?

27:17 - Integration of Electronic Medical Records (EMR)/EHR data

29:47 - Can the patient's health data be submitted by their provider or hospital?

33:26 - Message to those interested in Medical Affairs or this platform

36:13 - How are you stretching yourselves and lifting others in your next project?

36:36 - Key Lessons from Vinay and Gibu: "Be bold. The only way you will find the answer is by asking the question and taking that first step. By being bold you find out that you are capable of a lot more than you think. Be ready to adapt."

This is an episode recorded a few months ago after my guest, Johan Lauritsen, CEO & Founder of PROBE, had won the Evidence Generation category in the first-ever Medical Affairs Innovation Olympics hosted by Amedea Pharma. Johan is a medical student with prior gene editing experience, entrepreneur, keynote speaker, as well as a chronic Spinal Muscular Dystrophy type 2 patient. He is dedicating himself to facilitating and accelerating appropriate and timely patient access to clinical trials by developing a new program that researches and lists all the clinical trials across the globe for which a patient who is subscribed to his program is eligible based on health records submitted, and even directly connects the patients to the research investigator of the given study. Johan's passion and professionalism are both incredible gifts we can admire as he is in the progress of publishing the company's first prototype which is aimed at accelerating innovation in healthcare and democratizing patient participation, screening, and management of their own health. Lauritsen speaks about his personal journey as a chronic patient, and his modern perspectives on adding knowledge, transparency and technology to make clinical trials more accessible to all patients and relevant to them. Enjoy this candid conversation which showcases a new solution to improve health equity, health literacy, and patient engagement in research. You will hear Johan's tremendous accomplishments and calls to action for patients, their relatives and healthy volunteers to sign up for clinical trials and participate. 1:38 Can you share your unique background with the audience? 1:53 Johan was born with Spinal Muscular Dystrophy Type 2 (5qsma2) 5:59 For those not in healthcare, can you describe CRISPR gene editing? 8:03 Can you describe some of the processes people to know about and how clinical trials have changed. 13:25 Q: Is there routine prenatal screening or testing for SMA? In late 2022, all hospitals in Denmark implemented pre-natal screening for SMA. Johan fell when he was 3 and could no longer get back up. 14:33 SMA patients have won the Olympics before as well as the first ever Medical Affairs Innovation Olympics in the case of Johan 17:23 How has the data exchange in clinical trials accelerated and improved lately to ensure patients know about their results as soon as possible? 18:24 Clinical trials represent the most expensive, time consuming, and critical part of drug development. Patient recruitment continues to be a challenge because inclusion criteria are often determined from the investigators' perspectives rather than those of patients. Patients' inclusion criteria have now become more loose, allowing us to include more patients. 21:20 "Pharma companies do not have a realistic grasp of the real world patient population in a disease state for which they are developing treatments. Thus their study inclusion criteria are often inaccurate or irrelevant." 21:33 Only 15% of the minority populations are represented in clinical trials according to latest research. 22:10 Q: What is your company PROBE doing to improve access to clinical study for patients worldwide? 24:33 PROBE - While establishing a community of people that wants to participate in clinical trials, we are developing a tool that makes them accessible to them. We are also addressing health literacy as many patients want to be in a trial but they do not know where to find it or how to interpret the inclusion criteria or their own condition. 26:36 What kind of tool or app has PROBE created for clinical trial patients? 27:30 The App shows patients a list of clinical trials for which they are eligible. It connects the patients with the researchers, and therefore is a win-win for both researchers and patients. 29:47 Can the patient's health data be submitted by their provider or hospital? 31:34 Who are the members of the PROBE team? 34:13 Expecting to release its app at the end of January 2023.